mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |